BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 12382096)

  • 1. Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus.
    Lässker U; Harder TC; Hufnagel M; Suttorp M
    Infection; 2002 Oct; 30(5):320-2. PubMed ID: 12382096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
    Uebe B; Sauerbrei A; Burdach S; Horneff G
    Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes zoster in childhood.
    Leung AK; Robson WL; Leong AG
    J Pediatr Health Care; 2006; 20(5):300-3. PubMed ID: 16962434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary varicella-zoster virus infection--current knowledge, diagnostic and therapeutic approaches].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I
    Med Pregl; 2000; 53(5-6):272-6. PubMed ID: 11089369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
    Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
    Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells.
    Levy O; Orange JS; Hibberd P; Steinberg S; LaRussa P; Weinberg A; Wilson SB; Shaulov A; Fleisher G; Geha RS; Bonilla FA; Exley M
    J Infect Dis; 2003 Oct; 188(7):948-53. PubMed ID: 14513412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
    Sauerbrei A; Wutzler P
    J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
    Quinlivan M; Gershon AA; Steinberg SP; Breuer J
    J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
    Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
    Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method.
    Tang YW; Allawi HT; DeLeon-Carnes M; Li H; Day SP; Schmid D
    J Clin Virol; 2007 Oct; 40(2):129-34. PubMed ID: 17728179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complications in two children with acute lymphatic leukemia caused by vaccination against varicella zoster virus].
    Christensen CL; Poulsen A; Böttiger B; Kirk M; Andersen HK; Schmiegelow K
    Ugeskr Laeger; 1999 Feb; 161(6):794-6. PubMed ID: 10068350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification and sequencing of varicella-zoster virus (VZV) gene 4: point mutation in a VZV strain causing chickenpox during pregnancy.
    Chow VT; Lim KP
    Acta Virol; 1997 Oct; 41(5):277-83. PubMed ID: 9607081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory characteristics of suspected herpes zoster in vaccinated children.
    Chun C; Weinmann S; Riedlinger K; Mullooly JP; Houston H; Schmid DS; Seward JF
    Pediatr Infect Dis J; 2011 Aug; 30(8):719-21. PubMed ID: 21346684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
    Quinlivan ML; Gershon AA; Steinberg SP; Breuer J
    J Infect Dis; 2004 Aug; 190(4):793-6. PubMed ID: 15272408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.